Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
long intergenic non-protein coding RNA 1568 (abbreviated as LINC01568 and also known as LOHAN2) is a human long non-coding RNA (lncRNA) gene located on chromosome 16[1][2][9]. It is named for its upregulation and potential oncogenic function in head and neck cancers[1][7]. lncRNAs like LINC01568 typically do not encode proteins but participate in regulating gene expression at transcriptional and post-transcriptional levels. In cancer contexts, certain lncRNAs act as oncogenes, promoting tumor growth, proliferation, migration, and metastasis. Although many lncRNAs (including LINC01568) are emerging as therapeutic targets and potential biomarkers in oncology—especially in head and neck malignancies—the precise molecular mechanisms and validated therapeutic interventions for LOHAN2/LINC01568 remain under current investigation[5][7][9][10].
General mechanisms targeting lncRNAs include RNA interference (e.g., siRNA, antisense oligonucleotides) and nonspecific effects of chemotherapies that modulate lncRNA expression in cancer cells
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on long intergenic non-protein coding RNA 1568 (LINC01568).